WP

Wayne Paterson

Anteris Technologies Ltd | Managing Director, Chief Executive Officer
Mr. Paterson held senior positions at Merck KGaA (Merck), a science and technology company, from 2005 to 2013, including as President of Europe, Canada and Australia, President of Emerging Markets, President of Japan and President of Cardiovascular Medicine. From 1999 until 2005, Mr. Paterson served at Roche Pharmaceuticals, a multinational healthcare company, in several senior positions, including as Head of Pharmaceuticals in Roche's South Korean operation and Head of Commercial Operations for Roche China.

Company and Roles

Company
Title
Tenure
Since
AVR
AVR
Anteris Technologies Ltd
  • Managing Director
  • Chief Executive Officer
8yrs, 7mthFeb 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AVR
AVR
Anteris Technologies Ltd
19/06/2420,334N/A1,583,415N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AVR
AVR
Anteris Technologies Ltd
19/06/24
Issued
300,000$19.000$5,700,000Issue of options
AVR
AVR
Anteris Technologies Ltd
22/03/24
Cancelled
117,000$22.940$2,683,980Cancellation of securities
AVR
AVR
Anteris Technologies Ltd
15/09/23
Issued
700,000$20.300$14,210,000Issue of options
AVR
AVR
Anteris Technologies Ltd
31/05/23
Issued
4,167$23.800$99,174Issue of options
AVR
AVR
Anteris Technologies Ltd
31/05/23
Issued
4,167$24.000$100,008Issue of securities